Form 4: Saul Centers Director John Chapoton Acquires Shares and Holds Stock Options
SEC Form 4
Director John Chapoton acquired 2,000 shares of Saul Centers common stock and holds various stock options and phantom stock units.
Summary
- On May 17, 2024, John Chapoton, a director of Saul Centers, Inc., acquired 2,000 shares of common stock.
- The acquisition was made at a price of $0 per share, suggesting it was a grant or award.
- Following the transaction, Chapoton directly owns 9,466.078 shares of common stock.
- Chapoton also holds multiple director stock options with varying exercise prices and expiration dates, each for 2,500 shares of common stock.
- Additionally, Chapoton holds 24,045.973 phantom stock units through the company's Deferred Compensation Plan.
- These phantom stock units are payable in cash or common stock upon termination of service, at Chapoton's election.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares and holding of stock options suggest confidence, but it's a routine filing.
Positives
- The acquisition of 2,000 shares by a director could be seen as a positive signal, indicating confidence in the company's future.
- The director's continued holding of stock options demonstrates a long-term commitment to the company's success.
- The Deferred Compensation Plan allows directors to align their interests with those of shareholders.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge sentiment and potential future performance.
Stakeholder Impact
- The director's stock acquisition could positively influence shareholder sentiment.
- The Deferred Compensation Plan impacts the director's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date of Director Stock Option grant with an exercise price of $51.07 and an expiration date of 05/08/2025 |
| 05/06/2016 | Date of Director Stock Option grant with an exercise price of $57.74 and an expiration date of 05/06/2026 |
| 05/05/2017 | Date of Director Stock Option grant with an exercise price of $59.41 and an expiration date of 05/05/2027 |
| 05/11/2018 | Date of Director Stock Option grant with an exercise price of $49.46 and an expiration date of 05/11/2028 |
| 05/03/2019 | Date of Director Stock Option grant with an exercise price of $55.71 and an expiration date of 05/03/2029 |
| 04/24/2020 | Date of Director Stock Option grant with an exercise price of $50 and an expiration date of 04/24/2030 |
| 05/07/2021 | Date of Director Stock Option grant with an exercise price of $43.89 and an expiration date of 05/07/2031 |
| 05/13/2022 | Date of Director Stock Option grant with an exercise price of $47.9 and an expiration date of 05/13/2032 |
| 05/12/2023 | Date of Director Stock Option grant with an exercise price of $33.79 and an expiration date of 05/12/2033 |
| 04/30/2024 | 397.408 shares awarded as dividend reinvestments on shares of phantom stock |
| 05/17/2024 | Date of transaction where John Chapoton acquired 2,000 shares of common stock. |
| 05/17/2024 | Vesting start date for restricted shares of Common Stock, vesting on the first three anniversaries in equal annual installments. |
| 05/21/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.